Health and Global Policy Institute (HGPI) will hold a public symposium titled “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” on August 28, 2024.

Chronic kidney disease (CKD) in its early stages is characterized by a lack of noticeable symptoms, and it is said to be a new national disease, affecting one in seven adults. Efforts by stakeholders in Japan have led to steady progress in CKD management, including raising awareness, improving healthcare infrastructure at the community level, enhancing standards of care, developing human resources, and advancing research and development. However, the increase in the number of dialysis patients (due to both rising incidence and prevalence rates) continues unchecked, with further escalation expected due to Japan’s aging population.

In 2022, HGPI launched the “Kidney Disease Control Promotion Project” and formed a public-private-academic-civic advisory board. HGPI held meetings advocating for the importance of CKD prevention and early intervention, the significance of multidisciplinary and multisectoral collaboration, the need to expand successful local government initiatives, and the promotion of kidney disease strategies based on patient and stakeholder perspectives. In FY2023, HGPI further refined the recommendations from FY2022, conducted interviews about successful local government CKD strategies and challenges, deliberated on solutions to promote CKD initiatives in regions based on these findings, and compiled a policy recommendation document aligned with the patient journey to raise awareness. In addition, lifestyle-related disease meetings were held in Fukuoka City and Sendai City, bringing together administrative officials from local governments. These meetings were held with the aim to exchange views on the need to promote policies across lifestyle-related diseases and to strengthen cooperation among multiple professions and organizations. The resulting findings helped to clarify and summarize issues.

In the third year, FY2024, HGPI will organize a public symposium co-hosted by the Japan Kidney Association. This symposium aims to disseminate the exemplary cases, challenges, solutions discussed, and other outcomes obtained through HGPI’s past activities with society. It will bring together a wide range of stakeholders including governmental bodies (both central and local), legislators, academics, healthcare professionals, and patients/citizens involved in kidney disease management nationwide. The symposium aims to promote collaboration towards the realization of the next steps in patient- and citizen-led CKD strategies.

[Event Overview]

• Date & Time: Wednesday, Aug 28, 2024; from 13:00-18:00 (open from 12:45) JST
• Format:Hybrid (In-Person and Online (Zoom Webinars))
• Venue: International House of Japan (5-11-16 Roppongi, Minato-ku, Tokyo)
• Language: Japanese
• Participation Fee: Free
• Capacity: Venue: 100 / Online: 500
• Organizer: Health and Global Policy Institute (HGPI)
• Co-organizer: Japan Kidney Association

*The deadline to register for on-site attendance is August 14 (Wednesday) at 12:00 PM. If applications exceed the venue capacity, a lottery will be conducted. Notifications regarding the status of on-site attendance will be sent to the registered email addresses by August 16 (Friday).

**After completing registration, a confirmation email will be automatically sent to the registered email address. If you do not receive any confirmation, please contact info@hgpi.org.
If the maximum capacity is not reached by August 23 (Friday) at 12:00 PM, registrations will continue to be accepted on this page.

[Program] (Titles omitted, in no particular order)